利洁时(ADR)股票讨论区

Analysts worry about Reckitt Benckiser's performance, suggesting it may continue to underperform market expectations. The company's journey back to steady growth is in its early stages, with focus on its nutrition business. Concerns arise that this might not be a one-off incident and the company needs to demonstrate consistent growth and profitability post-pandemic.

RBC analysts led by James Jones described Reckitt's results as 'grim rather than just poor' as they said their 'expectations were subdued and Reckitt has undershot them.'